Cargando…
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
We sought to investigate anticancer efficacy of a vascular disrupting agent (VDA) combretastatin A-4 phosphate (CA4P) in relation to tumor size among hepatocellular carcinomas (HCCs) in rats using magnetic resonance imaging (MRI) and postmortem techniques. Nineteen rats with 43 chemically-induced HC...
Autores principales: | Liu, Yewei, Yin, Ting, Keyzer, Frederik De, Feng, Yuanbo, Chen, Feng, Liu, Jianjun, Song, Shaoli, Yu, Jie, Vandecaveye, Vincent, Swinnen, Johan, Bormans, Guy, Himmelreich, Uwe, Oyen, Raymond, Zhang, Jian, Huang, Gang, Ni, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589653/ https://www.ncbi.nlm.nih.gov/pubmed/28903414 http://dx.doi.org/10.18632/oncotarget.19339 |
Ejemplares similares
-
Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019) -
Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology
por: Yin, Ting, et al.
Publicado: (2017) -
Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
por: Liu, Yewei, et al.
Publicado: (2020) -
Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
por: Liu, Ye-Wei, et al.
Publicado: (2018) -
Visualization, Quantification and Characterization of Caerulein-Induced Acute Pancreatitis in Rats by 3.0T Clinical MRI, Biochemistry and Histomorphology
por: Yin, Ting, et al.
Publicado: (2017)